This paper is in the following e-collection/theme issue:

#PREreview Live Review Report (11)

Published on in Vol 6 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71293, first published .
Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Authors of this article:

Vanessa Fairhurst1 ;   Randa Salah Gomaa Mahmoud2 Author Orcid Image ;   Toba Olatoye3 Author Orcid Image ;   Sylvester Sakilay Author Orcid Image
Article Authors Cited by Tweetations Metrics

Vanessa Fairhurst   1 ;   Randa Salah Gomaa Mahmoud   2 ;   Toba Olatoye   3 ;   Sylvester Sakilay  

1 PREreview, Portland, OR, United States

2 Faculty of Human Medicine, Zagazig University, Zagazig, Egypt

3 University of Ilorin, Ilorin, Nigeria